News for SMS Pharmaceuticals Limited (SMSPHARMA.NS)

Jun 02, 2025 / 05:30AM GMTOperator Ladies and gentlemen, good day, and welcome to the SMS Pharmaceuticals Limited Q4 and FY25 Earnings Conference Call. This con

Aug 07, 2024 / 05:30AM GMTOperator Ladies and gentlemen, good day and welcome to SMS Pharmaceuticals Limited Q1 FY25 earnings conference call. This conference c

May 31, 2024 / 05:30AM GMTOperator Ladies and gentlemen, good and welcome to the SMS Pharmaceuticals Limited Q4 FY24 earnings conference call. This conference c

Aug 10, 2023 / 06:30AM GMTOperator Ladies and gentlemen, good day, and welcome to the SMS Pharmaceuticals Limited Q1 FY24 earnings conference call. This confere

Stocks to watch: Check out the companies making headlines before the opening bell today, on March 04, 2024.

Quant Small Cap Fund picked up 93,20,000 shares or a 4.37 percent stake at an average price of Rs 196.33

During this week, BSE Mid-cap index shed 1.3 percent, BSE Small-cap Index shed 0.8 percent and BSE Large-cap Index was down 0.5 percent.

As per the pivot charts, the key support level for the Nifty is placed at 17,758, followed by 17,708. If the index moves up, the key resistance levels to watch out for are 17,879 and 17,951.

SMS Pharmaceuticals has received a non-exclusive license to manufacture and supply of nirmatrelvir through the Medicine Patent Pool to manufacture nirmatrelvir, an oral anti-viral Covid-19 medicine.

BSE Sensex and Nifty 50 were dancing in between gains and losses on Friday

Mazhar Mohammad of Chartviewindia.in said Nifty will need to sustain above the gap zone of 16,176-16,146 to retain the positive bias. "If the bulls manage to defend the said support, a higher target towards 16,700 can be expected," he said.

Sensex slipped below the 52,000 mark, while Nifty ended below the crucial 15,550 level.

Trends on SGX Nifty indicate a positive opening for the index in India with a 49 points gain.

Any sustainable move above 15,380 levels may cause momentum towards 15,450-15,550 levels, said Rajesh Palviya of Axis Securities.